<SUBMISSION>
<ACCESSION-NUMBER>0000950129-05-003236
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20050330
<ITEMS>1.01
<ITEMS>9.01
<FILING-DATE>20050401
<DATE-OF-FILING-DATE-CHANGE>20050401
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>LEXICON GENETICS INC/TX
<CIK>0001062822
<ASSIGNED-SIC>2835
<IRS-NUMBER>760474169
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-30111
<FILM-NUMBER>05726181
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>8800 TECHNOLOGY FOREST PLACE
<CITY>THE WOODLANDS
<STATE>TX
<ZIP>77381
<PHONE>2818633000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>8800 TECHNOLOGY FOREST PLACE
<CITY>THE WOODLANDS
<STATE>TX
<ZIP>77381
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>h24015e8vk.txt
<DESCRIPTION>LEXICON GENETICS INC.- MARCH 28, 2005
<TEXT>
<PAGE>
================================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

                               ------------------

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


        DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MARCH 28, 2005


                          LEXICON GENETICS INCORPORATED
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


<Table>
<Caption>
                DELAWARE                    000-30111                   76-0474169
<S>                                  <C>                         <C>
 (STATE OR OTHER JURISDICTION OF     (COMMISSION FILE NUMBER)       (I.R.S. EMPLOYER
  INCORPORATION OR ORGANIZATION)                                  IDENTIFICATION NUMBER)
</Table>


                          8800 TECHNOLOGY FOREST PLACE
                           THE WOODLANDS, TEXAS 77381
                         (ADDRESS OF PRINCIPAL EXECUTIVE
                              OFFICES AND ZIP CODE)


                                 (281) 863-3000
                         (REGISTRANT'S TELEPHONE NUMBER,
                              INCLUDING AREA CODE)


         Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

         [ ]      Written communications pursuant to Rule 425 under the
                  Securities Act (17 CFR 230.425)

         [ ]      Soliciting material pursuant to Rule 14a-12 under the Exchange
                  Act (17 CFR 240.14a-12)

         [ ]      Pre-commencement communications pursuant to Rule 14d-2(b)
                  under the Exchange Act (17 CFR 240.14d-2(b))

         [ ]      Pre-commencement communications pursuant to Rule 13e-4(c)
                  under the Exchange Act (17 CFR 240.13e-4(c))

================================================================================


<PAGE>


ITEM 1.01         ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

         On March 28, 2005, we entered into an agreement with C. Thomas Caskey,
M.D., a member of our board of directors, under which Dr. Caskey will serve as a
consultant to us on governmental affairs. Dr. Caskey will receive payment of
$75,000 per year, payable in monthly installments, for his consulting services
under the agreement. The agreement has an initial term of one year and may be
extended by mutual agreement of the parties.

         A copy of the consulting agreement is attached to this current report
on Form 8-K as Exhibit 10.1.

ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS

         (c)      Exhibits


<Table>
<Caption>
  EXHIBIT NO.                         DESCRIPTION
  -----------                         -----------
<S>               <C>
     10.1     --  Consulting Agreement with C. Thomas Caskey, M.D. dated March 28, 2005
</Table>


                                       2

<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                               LEXICON GENETICS INCORPORATED


Date: April 1, 2005                             By: /s/ JEFFREY L. WADE
                                                    ----------------------------
                                                    Jeffrey L. Wade
                                                    Executive Vice President and
                                                    General Counsel

                                       3
<PAGE>

                                INDEX TO EXHIBITS

<Table>
<Caption>
  EXHIBIT NO.                         DESCRIPTION
  -----------                         -----------
<S>               <C>
     10.1     --  Consulting Agreement with C. Thomas Caskey, M.D. dated March 28, 2005
</Table>



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>h24015exv10w1.txt
<DESCRIPTION>CONSULTING AGREEMENT - C. THOMAS CASKEY, M.D.
<TEXT>
<PAGE>
                                                                    EXHIBIT 10.1

                          [LEXICON GENETICS LETTERHEAD]


                                 March 28, 2005

VIA FEDERAL EXPRESS
Dr. C. Thomas Caskey
Five Post Oak Park
4400 Post Oak Parkway, Suite 1400
Houston, Texas 77027

Dear Tom:

         We are pleased to invite you to become a consultant to Lexicon Genetics
Incorporated (which, together with its subsidiaries and affiliates, is referred
to as the "Company" or "Lexicon") relating to Lexicon's interactions with
federal and state government representatives and agencies regarding
opportunities for grants, collaborations and other contracts. The purpose of
this letter agreement (this "Agreement") is to set forth our mutual
understanding of the terms and conditions under which you would provide
consulting services, as set forth below.

         1. Consulting Services. As a consultant to Lexicon, you will provide
such consulting and advisory services as may be requested by Arthur T. Sands,
M.D., Ph.D., the Company's President and Chief Executive Officer, relating to
Lexicon's interactions with federal and state government representatives and
agencies regarding opportunities for grants, collaborations and other contracts.
You will devote up to 24 days annually (approximately two days a month on
average) to providing such services to the Company under this Agreement, on a
schedule and at times reasonably agreed upon by you and Dr. Sands.

         2. Compensation. As full consideration for your services as a
consultant to the Company and your obligations under this Agreement, you will
receive fees of $75,000 per year, payable in 12 monthly installments. In
addition, you will be reimbursed for your reasonable, ordinary and necessary
travel expenses incurred by you at the Company's prior request in connection
with your performance of your services under this Agreement.

         3. Confidential Information.

                  (a) In the course of your service as a consultant to the
         Company, you may learn or be exposed, orally, visually, electronically
         or in writing, to inventions, discoveries, improvements, materials,
         data, technology, processes, formulas, know-how, trade secrets, ideas
         and other information which we consider proprietary or confidential
         ("Confidential Information"). You agree to hold any Confidential
         Information disclosed to you by the Company or learned by you from the
         Company in conjunction with your services under this Agreement in
         strict confidence and to take all reasonable precautions to protect
         such Confidential Information, not to disclose any such Confidential
         Information to any third party, and to use such Confidential
         Information only in furtherance of your services under this Agreement;
         provided that your nondisclosure obligation shall not apply to the
         extent such Confidential Information (i) is already in the public
         domain or hereafter enters the public domain other than through your
         acts or omissions in violation of this Agreement; (ii) is already known
         to you, as may be shown by competent written records; (iii) is
         hereafter received by you without restriction as to confidentiality or
         use from a

<PAGE>


         third party lawfully entitled so to disclose same in such manner; or
         (iv) is hereafter generated by you, other than in performance of your
         services under this Agreement, without the use of any Confidential
         Information, facilities or personnel of the Company. Information shall
         not be deemed to be within the foregoing exceptions merely because such
         information is embraced by more general information in the public
         domain or in your possession. All Confidential Information (and any
         copies and notes thereof) shall remain the sole property of the
         Company.

                  (b) You agree not to disclose or otherwise make available to
         the Company any information that you possess under an obligation of
         confidentiality to a third party. You may disclose to the Company any
         information made available generally to the scientific community at
         large through published reports or public presentations prior to
         disclosure to the Company.

         4. Term and Termination. You will render your advisory and consulting
services to the Company for an initial period of one year from the date of this
letter. The term of this Agreement may be extended by mutual written agreement
between you and the Company. This Agreement may be terminated (a) at any time by
either party, with or without cause, upon 30 days' advance written notice to the
other party and (b) by either party for breach of this Agreement by the other
party that, where curable, is not cured within 10 business days after written
notice of such breach is delivered to the breaching party.

         5. Independent Contractor. For purposes of this Agreement, you will be
deemed an independent contractor and not an employee or agent of Lexicon. In
this connection, you will not be eligible for, nor entitled to, any employee
benefits that we normally extend to our employees, and we will not withhold any
taxes from the compensation paid to you, all of which shall be your
responsibility. The manner in which you render your services under this
Agreement will be within your reasonable control and discretion. You have no
express or implied authority to incur any liability, or to make any decision or
to create any binding obligation, on our behalf.

         6. Compliance with Laws and Procedures. To the extent you provide
services under this Agreement on our premises, you agree to observe our business
hours, as well as our rules, policies and security procedures concerning conduct
and the health, safety and protection of persons and property. You will comply
with all applicable governmental laws, ordinances, rules and regulations
applicable to the performance of your services under this Agreement.

         7. Governing Law. This Agreement shall be governed by, and construed
and enforced in accordance with, the laws of the State of Texas as they apply to
contracts entered into and wholly to be performed in Texas.

         8. Enforcement. You agree that a breach of any of the restrictions set
forth in the provisions of this Agreement would cause the Company irreparable
injury and damage, and that, in the event of any breach or threatened breach,
the Company, in addition to all other rights and remedies at law or in equity,
shall have the right to enforce the specific performance of such restrictions
and to apply for injunctive relief against their violation.

         9. Survival of Terms. The provisions of Sections 3 and 7 through 15
hereof shall survive termination of this Agreement.

         10. Successors and Assigns. You may not assign this Agreement without
the written consent of the Company. This Agreement shall be binding on your
heirs, executors, administrators and legal representatives and the Company's
successors and assigns.

<PAGE>

         11. Severability. The invalidity or unenforceability of any provision
of this Agreement (or portion thereof) shall not affect the validity or
enforceability of any other provision of this Agreement, and if such provision
(or portion thereof) is so broad as to be unenforceable, it shall be interpreted
to be only as broad as is enforceable.

         12. Entire Agreement. This Agreement constitutes the sole and complete
agreement of the parties with respect to the matters included herein, and
supersedes any previous oral or written agreement, if any, relating to the
subject matters included herein.

         13. Amendment and Waiver. This Agreement may not be amended or
supplemented in any way, nor may the benefit of any provision hereof be waived,
except by a written agreement duly executed by both you and the Company.

         14. No Conflict. You represent that the performance of your obligations
and duties under this Agreement does not conflict with any obligations or
duties, express or implied, that you may have to third parties.

         15. Construction. Each party to this Agreement has had the opportunity
to review this Agreement with legal counsel. This Agreement shall not be
construed or interpreted against any party on the basis that such party drafted
or authored a particular provision, parts of or the entirety of this Agreement.

         16. Board Service. You and the Company acknowledge and agree that the
consulting relationship contemplated by this Agreement is separate and distinct
from your service as a member of the Company's Board of Directors, which service
shall be governed by (a) the terms and conditions of Company's Certificate of
Incorporation and By-Laws, in each case as amended; (b) applicable actions taken
by the Board of Directors; (c) the Delaware General Corporation Law; and (d)
other applicable federal and state laws.

<PAGE>

         If the foregoing correctly sets forth our mutual understanding, please
so indicate by signing this letter in the space provided below and return it to
the Company at the above address, whereupon this Agreement shall constitute a
binding contract between us and our legal representatives, successors, and
assigns.

                                       Very truly yours,

                                       LEXICON GENETICS INCORPORATED


                                       By: /s/ Arthur T. Sands
                                           -------------------------------------
                                           Arthur T. Sands, M.D., Ph.D.
                                           President and Chief Executive Officer



ACCEPTED AND AGREED TO ON THE DATE SET FORTH BELOW:


By: /s/ C. Thomas Caskey
    ----------------------
    C. Thomas Caskey, M.D.

Date: March 28, 2005

</TEXT>
</DOCUMENT>
</SUBMISSION>
